HighTower Advisors, LLC - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 335 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2017. The put-call ratio across all filers is 1.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q1 2018$4,721,000
-12.9%
335,516
-40.2%
0.04%
-13.3%
Q4 2017$5,422,000
+191.2%
560,612
+328.2%
0.04%
+181.2%
Q3 2017$1,862,000
+102.6%
130,929
+140.7%
0.02%
+100.0%
Q2 2017$919,000
+145.7%
54,387
+56.6%
0.01%
+100.0%
Q1 2017$374,000
-33.2%
34,728
-10.5%
0.00%
-33.3%
Q4 2016$560,000
-62.3%
38,803
-36.3%
0.01%
-64.7%
Q3 2016$1,487,000
+13.9%
60,919
-7.4%
0.02%0.0%
Q2 2016$1,305,000
-35.4%
65,820
+157.7%
0.02%
+183.3%
Q1 2016$2,020,000
+287.0%
25,538
+399.9%
0.01%0.0%
Q4 2015$522,000
-79.1%
5,109
-63.6%
0.01%
-81.8%
Q3 2015$2,498,000
-7.4%
14,021
+15.5%
0.03%
-23.3%
Q2 2015$2,697,000
+311.1%
12,141
+267.8%
0.04%
+330.0%
Q1 2015$656,000
+51.9%
3,301
+9.3%
0.01%
+42.9%
Q4 2014$432,000
+11.1%
3,021
+2.0%
0.01%0.0%
Q3 2014$389,000
-41.4%
2,962
-43.8%
0.01%
-41.7%
Q2 2014$664,000
-10.3%
5,266
-6.2%
0.01%
-14.3%
Q1 2014$740,000
+30.5%
5,616
+16.2%
0.01%
+16.7%
Q4 2013$567,000
+43.9%
4,833
+30.4%
0.01%
+20.0%
Q3 2013$394,000
+17.6%
3,706
-4.6%
0.01%
+11.1%
Q2 2013$335,0003,8860.01%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q1 2017
NameSharesValueWeighting ↓
Chou Associates Management 1,648,992$38,323,00014.52%
Paulson & Co. 20,839,035$484,299,0009.89%
MILLER VALUE PARTNERS, LLC 4,999,064$116,178,0004.34%
GoldenTree Asset Management 1,140,205$26,498,0004.21%
Pomelo Capital LLC 1,760,000$40,902,0004.00%
Bruce & Co., Inc. 860,000$19,986,0003.98%
ValueAct Holdings 18,033,149$419,090,0003.79%
Stanley Capital Management, LLC 318,400$7,400,0003.25%
Kazazian Asset Management, LLC 134,784$3,132,0002.87%
Phoenix Investment Adviser LLC 58,400$1,357,0002.48%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders